Effectiveness of liposomal bupivacaine in adductor canal blocks for pediatric knee procedures: A case series

J Clin Anesth. 2021 Dec:75:110517. doi: 10.1016/j.jclinane.2021.110517. Epub 2021 Sep 9.

Abstract

Adductor canal block (ACB) using liposomal bupivacaine (LB) has been shown to be effective in achieving prolonged postoperative pain control for knee procedures in adults. However, published literature on the use of ACB with LB in pediatric patients continues to be lacking. We present a case series on the effectiveness of ACB using LB in achieving extended postoperative pain control for pediatric patients undergoing knee surgeries. Our patients reported at least 96 h of pain relief with zero postoperative opioid requirements and no major adverse reactions from LB.

Keywords: Adductor canal block; Liposomal bupivacaine; Pediatric regional anesthesia.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Analgesics, Opioid
  • Anesthetics, Local / adverse effects
  • Arthroplasty, Replacement, Knee* / adverse effects
  • Bupivacaine / adverse effects
  • Child
  • Humans
  • Nerve Block* / adverse effects
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / prevention & control

Substances

  • Analgesics, Opioid
  • Anesthetics, Local
  • Bupivacaine